A phage against E. coli must prove its value in the actual meat matrix

A bacteriophage targeting Escherichia coli from raw meat shows potential as a biocontrol tool, but not yet as a practice-ready solution. A study published in Scientific Reports collected 60 swab samples from raw red meat in butcher shops in Iran’s Zanjan Province. E. coli was isolated from 37 samples, representing 61.7% of the investigated series.

The isolates frequently showed resistance to tetracycline, trimethoprim-sulfamethoxazole and amoxicillin, and some carried beta-lactamase genes. Researchers isolated a lytic phage from wastewater and tested it against the 37 E. coli strains recovered from meat. The phage produced clear lysis in 20 isolates, or 54.1%.

Thermal stability immediately defines its possible use. The phage retained activity between –20 and 55°C but was inactivated at 65°C. That makes it relevant primarily for interventions on raw product and within cold-chain conditions, not as a post-cooking measure. It also confirms a crucial limitation: a phage can be highly specific, yet it does not automatically cover every variant of a pathogen.

The appropriate conclusion is not that a treatment for fresh meat is now available. The authors call for trials in food matrices and for further work on stability, safety and applicability before practical use. For industry, the finding reinforces a wider principle: phages may become an additional barrier, but they must be validated by product, target strain, dose, temperature and process. Basic hygiene and representative sampling remain indispensable.